Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04296890
Title A Study of Mirvetuximab Soravtansine in Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression (SORAYA)
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors ImmunoGen, Inc.
Indications

ovarian serous carcinoma

fallopian tube cancer

peritoneum cancer

Therapies

Mirvetuximab Soravtansine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.